Cancer Care In The COVID-19 Era: Exact Sciences Touts Data For Oncotype Dx Breast Test
Executive Summary
As hospitals struggle to prioritize care during the pandemic, molecular and genomic tests are proving helpful in distinguishing patients eligible for neoadjuvant therapy whilst surgical capacity is limited.